← Back to Clinical Trials
Recruiting NCT06577857
Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Trial Parameters
Condition Open Angle Glaucoma
Sponsor Sanoculis Ltd
Study Type OBSERVATIONAL
Phase N/A
Enrollment 53
Sex ALL
Min Age 40 Years
Max Age 85 Years
Start Date 2022-11-04
Completion 2025-06-30
Interventions
Inferonasal Minimally Invasive Micro Sclerostomy
Brief Summary
A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).
Eligibility Criteria
Inclusion Criteria: 1\. Subject who underwent MIMS® inferonasal procedure, and surgery was performed not earlier than 24 months from enrollment